There may be some applications in the TMVR space but at the moment all we are concerned about right now is ticking the FDA’s boxes to get the green light for the TAVR early feasibility Study (EFS).
A lot of investors may not realise it now but this innovation combined with DurAVR almost assures us of Breakthrough status (IMHO).
DYOR and Not advice.
ComASUR™ TF Del System, page-5
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |